Annovis Bio News

Maxim Group Upgrades Annovis Bio(ANVS.US) to Buy Rating, Announces Target Price $25

Moomoo NewsOct 25 08:31 ET

Annovis Bio Price Target Announced at $25.00/Share by Maxim Group

Dow JonesOct 25 08:22 ET

Annovis Bio Analyst Ratings

BenzingaOct 25 08:12 ET

Annovis Bio Upgraded to Buy From Hold at Maxim

TipRanksOct 25 07:37 ET

H.C. Wainwright Maintains Annovis Bio(ANVS.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsOct 16 06:31 ET

Annovis Bio Is Maintained at Buy by EF Hutton

Dow JonesOct 15 12:48 ET

Annovis Bio Analyst Ratings

BenzingaOct 1 07:09 ET

H.C. Wainwright Maintains Annovis Bio(ANVS.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsOct 1 06:31 ET

CCORF Maintains Annovis Bio(ANVS.US) With Buy Rating, Maintains Target Price $26

Moomoo NewsSep 3 08:33 ET

Buy Rating on Annovis Bio Amid Progress in PD and AD Drug Development

TipRanksSep 3 07:48 ET

Maxim Group Maintains Annovis Bio(ANVS.US) With Hold Rating

Moomoo NewsAug 16 13:32 ET

Annovis Bio (ANVS) Receives a Hold From Maxim Group

TipRanksAug 16 12:57 ET

Annovis Bio Price Target Maintained With a $21.00/Share by EF Hutton

Dow JonesAug 15 16:32 ET

Annovis Bio Analyst Ratings

BenzingaAug 15 07:41 ET

Buy Rating Affirmed for Annovis Bio Amid Promising Buntanetap Trials and Stable Financials

TipRanksAug 15 06:31 ET

H.C. Wainwright Maintains Annovis Bio(ANVS.US) With Buy Rating, Maintains Target Price $30

Moomoo NewsAug 15 06:31 ET

Annovis Bio Analyst Ratings

BenzingaAug 13 07:39 ET

EF Hutton Initiates Annovis Bio(ANVS.US) With Buy Rating, Announces Target Price $21

Moomoo NewsAug 13 07:31 ET

Maxim Group Keeps Their Hold Rating on Annovis Bio (ANVS)

TipRanksAug 7 13:58 ET

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Sensei Biotherapeutics (SNSE) and Annovis Bio (ANVS)

TipRanksAug 7 06:49 ET